Skip to content

ROBYN Study - Robotic Assisted Surgery in Gynecological Indications Compared to Conventional Laparoscopy

ROBYN Study - Robotic Assisted Surgery in Gynecological Indications Compared to Conventional Laparoscopy - A Prospective, Non-Interventional, Multinational, Post-Market Clinical Investigation

Status
Withdrawn
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05496244
Acronym
ROBYN
Enrollment
0
Registered
2022-08-11
Start date
2022-11-30
Completion date
2030-12-31
Last updated
2023-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

GYN Disorders

Brief summary

Robotic Assisted Surgery (da Vinci System) in gynecological indications compared to conventional laparoscopy

Detailed description

A Prospective, Non-Interventional, Multinational, Post-Market Clinical Investigation

Interventions

DEVICELaparoscopy

Laparoscopic surgery

Robotic-assisted surgery

Sponsors

Intuitive Surgical
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Key Inclusion Criteria: * Patient is willing to participate and to comply with the study procedures * Patient present with gynecological disease that may be treated with surgical intervention Key

Exclusion criteria

* Life expectancy for less than 1 year

Design outcomes

Primary

MeasureTime frameDescription
Complications of medical interest90 daysDescribe complication of medical interest
Describe treatment decisionEnrollment CompletionDescribe treatment decision for the procedure of choice
Describe patient outcome12 MonthsDescribe patient outcome from robotic-assisted surgery and conventional laparoscopy by using physiological parameter such as relief or improvement of symptoms, number of complications or number of re-operations and changes in the patient reported quality of life (EQ-5D-5L) between baseline and FU at 12 Months (changes in the score)
Describe impact of patient factors on outcome12 MonthsDescribe impact of patient factors on outcome by using physiological parameter, such as age, BMI, uterus size, report co-morbidities

Secondary

MeasureTime frameDescription
Quality of Life Impact per patient reported questionnaires12 MonthsDescribe Quality of Life impact as assessed via patient reported questionnaires; changes in quality of life questionnaires scores between baseline and up to follow-up 12 months will be assessed (EQ-5D-5L on mobility, self-care, usual activities, pain/discomfort, anxiety/depression)
Describe the impact of surgeon experience on outcome12 MonthsDescribe the impact of surgeon experience on outcome; individual surgeon experience will be collected (self-reported by surgeon) and linked to every performed procedure; descriptive assessment if the reported surgeon experience has an impact on the outcome, e.g. number of reported complications. As surgeon experience, the number of performed procedures per indication and technique (robotic-assisted surgery or laparoscopy will be collected), as well as the overall years the surgeon is performing surgeries.
Describe the performance and use of Intuitive instruments12 MonthsDescribe the performance and use of Intuitive instruments; information on any device failure or device deficiency will be collected and descriptively assessed
Describe the performance and use of Intuitive systems12 MonthsDescribe the performance and use of Intuitive systems; information on any device failure or device deficiency will be collected and descriptively assessed

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026